Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
GLP-1R (human):Fc (LALA-PG)-KIH (human) (rec.)

Method: The ligands Tirzepatide (Prod. No. AG-CP3-0043) and Semaglutide (Prod. No. AG-CP3-0040) are coated on an ELISA plate at 500nM overnight at room temperature. GLP-1R (human):Fc (LALA-PG)-KIH (human) (rec.) or a control protein hIL-2-KIH (Prod. No. AG-40B-0263) (data not shown) is added starting at 160nM with a twofold serial dilution during one hour and then detected using a human Fc (HRP) antibody.
Product Details | |
---|---|
Synonyms | InVivoKine™; GLP-1R (human) Fc (LALA-PG) Knobs-into-Holes (human) (rec.); Glucagon-like Peptide 1 Receptor; GLP1R |
Product Type | Protein |
Properties | |
Source/Host | HEK 293 cells. Produced using animal component-free medium. |
Sequence |
Extracellular domain of human GLP-1R (aa 24-139) is fused at the C-terminus to the Fc portion of human IgG1 (LALA-PG) (Knobs-into-Holes technology) (see reference: J.B. Ridgway, et al.; Protein Eng. 9, 617 (1996)). |
Crossreactivity |
Bovine Human Mouse Rat |
Application |
Binds to GLP-1, Semaglutide and Tirzepatide. Potential use for screening of new GLP-1R agonists. |
Specificity |
Human, Mouse, Rat, Bovine |
MW | ~65kDa and 28kDa (SDS-PAGE) |
Purity | ≥95% (SDS-PAGE) |
Endotoxin Content | <0.01 EU/μg protein (LAL test). |
Concentration | After reconstitution: 1mg/ml |
Reconstitution | Reconstitute with 50μl endotoxin-free water. |
Accession Number | P43220 |
Formulation | Lyophilized. Contains PBS. |
Protein Negative Control |
Fc (LALA-PG)-KIH (human) IgG1 Control (rec.) (Prod. No. AG-35B-0018) |
Other Product Data |
Uniprot link P43220: GLP-1R (human) |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
After reconstitution, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. Centrifuge lyophilized vial before opening and reconstitution. PBS containing at least 0.1% BSA should be used for further dilutions. |
Use/Stability |
Stable for at least 6 months after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C. |
Documents | |
Product Specification Sheet | |
Datasheet |
![]() |
Glucagon-like peptide 1 (GLP-1) is a 30-amino acid Incretin peptide hormone produced in the intestine by differential processing of proglucagon. Incretin hormones are gut peptides that are secreted after nutrient intake and stimulate insulin secretion together with hyperglycemia. GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) are the known incretin hormones from the upper (GIP, K cells) and lower (GLP-1, L cells) gut. GLP-1 receptors are abundant in the hypothalamus which contains projections to the hunger centers. GLP-1 decreases calorie intake, boosts feelings of satiety and encourages weight loss. GLP-1 and GIP hormones are used as drugs for weight loss in obese patients and also to lower blood sugar levels.
The protein GLP-1R (human):Fc (LALA-PG)-KIH (human) (rec.) is produced by using two different vectors, one encoding for the GLP-1R (human:Fc (LALA-PG) Knobs sequence (synthesizing a protein of 60kDa) and one encoding for the Fc (LALA-PG) Holes sequence (synthesizing a protein of 28kDa). Both vectors transfected into HEK293 cells produce both Fc molecules (Knobs-into-Holes technology; J.B. Ridgway, et al.; Protein Eng. 9, 617 (1996)) required for dimerization of the Fc moieties and for secretion of the final protein GLP-1R (human):Fc-KIH (human) (rec.). The LALA-PG mutations inhibit binding to FcγRs and C1q while FcRn binding and Fc stability remain unaffected.
InVivoKines™ are a new generation of recombinant fusion proteins for immunotherapeutic, preclinical and translational in vivo research, developed and manufactured by AdipoGen Life Sciences.